Timothy Patrick

TIMOTHY PATRICK is the President and Chief Executive Officer of Proxima
Therapeutics, Inc., a venture-backed medical device company. Proxima has
developed and commercialized local radiation therapy systems that reduce
treatment time for brain tumor and breast cancer patients. Mr. Patrick
has 20 years of experience in the medical device industry, focused
primarily on cancer therapy products. Prior to co-founding Proxima in
1996, Mr. Patrick was President of Gesco International, the leading
manufacturer of peripherally inserted central venous catheters. Gesco
and its parent company, MedChem Products, were acquired by C.R. Bard in
1995. Before serving as President of Gesco International, Mr. Patrick
ran two high growth divisions for McGaw Inc., serving most recently as
President of Central Admixture Pharmacy Services, an oncology drug
provider, and as Vice President and General Manager of the Alternate
Site Division. He also held a number of sales and sales management
positions at American Hospital Supply Corporation. Mr. Patrick serves as
a Director of the Georgia Biomedical Partnership and is a former
Director of Derma Sciences, Inc. He is an inventor on several patents
related to localized radiation delivery systems. Mr. Patrick earned his
Bachelor of Arts in Zoology from Miami University in Ohio.